A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, the determination of virus-neutralizing antibodies (NAbs) is indispe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Schöler, Lara, Le-Trilling, Vu Thuy Khanh, Eilbrecht, Mareike, Mennerich, Denise, Anastasiou, Olympia E., Krawczyk, Adalbert, Herrmann, Anke, Dittmer, Ulf, Trilling, Mirko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Immunology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581787/
https://ncbi.nlm.nih.gov/pubmed/33162987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.573526
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia